Citius Oncology, Inc. CTOR Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- Citius Oncology, Inc. (CTOR) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of 26.2% in Q3 2025.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- Represents adjustments to the effective tax rate resulting from changes in the valuation allowance against deferred tax assets. It indicates management's assessment of the recoverability of future tax benefits.